BioSerenTach Inc 本文へジャンプ
news

July, 2023

Japan patent on dissolving microneedles having adjuvant effet is approved

April, 2023
New type GI-MAPS patent in Japan is approved


January-
February, 2022



April 5, 2022
Kansai BioBusiness Matching

"Pharmaceutical Formulation of Peptide drug: DDS Technology", Chapter 2, Section 6 in Synthesis, Analysis, Production and Development Strategy of Peptide Drugs by R&D Support Center

New GI-MAPS US Patent is approved

September
27-29, 2021

European Biotech & Pharma Virtual Partnering Conference 2021

Microneedle cosmetics on the market are
・ SHOT MODE by Nissha Co., Ltd. from 2019
 https://connect.nissha.com/microneedle/
 https://shotmode.jp
・NEEDROP by NISSHA Co., Ltd., from 2020
 https://needrop.jp/order/
・ VC micro N Patch by Corefront Co., Ltd., from 2017
 https://www.corefront.com/cosme02.html
・others

June 29, 2020
NEEDROP was released from NISSHA Co., Ltd


April 2019 SHOTMODE; Microneedle cosmetics by NISSHA Co., Ltd.


October 10-12, 2018
・Japan Healthcare Venture Summit in Yokohama


October 11-13, 2017 BioSerenTach had an exhibition booth in Japan Healthcare Venture Summit, Yokohama.

・VC microN Patch was releassed from Corefront Co., Ltd.

April 1, 2016
・New office in Nakagyo-ku opens


October 14-16, 2015 BioSerenTach had an exhibition booth in BioJapan 2015.

April 10, 2015
・Award of best scientific report in J. Drug Deliv. Sci. Tecnol. was obtained with insulin glargine dissolving microneedles.


June 26, 2014 BioSerenTach made an alliance with Sanofi to develop new preparation of lixisenatide, a GLP-1 receptor agonist, by dissolving micropile technology.

July 23, 2013
・USA Patent Office granted a certificate of patent on multi-layered dissolving microneedles to BioSerenTach, where polysaccharide, protein and synthesic polymers are used as the base. The developments of 2- and 3-layered dissolving microneedles are accelerated.


February 4, 2013 TV asahi reported the usefullness of dissolving microneedle technology of BioSerenTach as skin vaccine for influenza.

October 5, 2012
・BioSerenTach licensed out the dissolving microneedles array chip technology to Nissha Printing Co., Ltd. in the field of cosmetics and quasi-pharmaceutical products.


January 27, 2012 Japan government, Patent Office, granted a certificate of patent on dissolving microneedles to BioSerenTach, where biopolymers, hyarulonic acid, chondroitin sulfate etc., are claimed as the base of dissolving microneedles.

November 9, 2011
・ Nippon TV news, Dissolving microneedle technology is reported as a novel DDS for painless infuenza vaccine. TV news is uploaded at the website of our NPO, Japan Health Supporting System, http://www.annpo.jp/


September 30, 2011 Two-layered dissolving microneedle producing machine is developed with the grant from the government.

February 22, 2010
Chimie Pharma hebdo, French scientific journal, reports GI-MAPS and Dissolving Microneedles of BioSerenTach as innovative DDS technologies.


February 1, 2010 ・Yomiuri shinbun, reports the skin vaccine by dissolving microneedle chip with which collaboration was performed with National Institute of Infectious Disease (NIID) of Japan.


December 22, 2009
Mainichi shinbun reports the pain-free vaccines and dissolving microneedle chip innovated by Prof. Takada, is focused as a new skin vaccine device.


Decembere15, 2009 ・DIME, the famous magazine in Japan published by Shogakkan, reports Dissolving microneedle chip of BioSerenTach as the delivery system of skin vaccine.


October 24, 2009
Asahi shinbun reports the pain-free self-dissolving microneedles of Prof. Takada, Kyoto Pharmaceutical University, as a new skin vaccine device.


September 26, 2009 Nikkei, the most famous economical news paper in Japan, reports self-dissolving microneedle array chip of BioSerenTach as the delivery system of skin vaccine.


December 8, 2008
・BioSerenTach obtains a grant from JST to develop a machine to produce microneedle array chip in larger scale.


August 13, 2008 ・Yakuji Nippou reports the results on the skin vaccine research performed with National Institute of Infectious Disease (NIID).


July 1, 2008
・One of the websites of our government introduces self-dissolving microneedle array chip of BioSerenTach as a pain-free injection using animation with the representative Japanese products such as G-shock watch and automobiles.


March 16, 2008 Asahi Shinbun (most famous newspaper in Japan) reported self-dissolving microneedle array chip of BioSerenTach as a novel TDDS with a big photo.


January 15,
2008
・BioSerenTach starts to produce microneedlle array chip as a contract manufacturing service.

・Machine to produce microneedlle array chip is now available.

December 10, 2007 ・BioSerenTach develops GI-MAPS producing machine which works under GMP condition with Toray Engineering Co. Ltd.

・BioSerenTach starts to supply GI-MAPS samples to pharmaceutical companies.

December 5, 2007
The following GI-MAPS patents are granted and have been registered till the end of 2007.

・United States Patent 7,097,851
・European Patent 1,135,112
・Australia Patent 766,293
・China Patent ZL99815818.6
・Korea Patent 10-0762475



Copyright BioSerenTach Inc. 2021